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Abstract
Background The senses of smell and taste can be adversely affected by both tumour- and treatment-related factors amongst 
head and neck cancer patients. The consequences may negatively impact nutritional status as well as quality of life in this 
patient population.
Patients and methods This prospective longitudinal follow-up study is consisted of 44 patients treated for oral cavity, 
oropharyngeal or hypopharyngeal cancer with tumour resection and microvascular free tissue transfer reconstruction at the 
Helsinki University Hospital, Helsinki, Finland. Thirty-nine (89%) of them also received radiotherapy. The senses of smell 
(odour detection, identification and threshold test) and taste (electrogustometry) and quality of life (UW-QOL) were evalu-
ated preoperatively, and at 6 weeks, 3 months, 6 months and 12 months, postoperatively.
Results There were higher scores in the odour detection values in the 6-week and 3-month tests compared with preoperative 
values for the tumour side. Other detection scores did not differ statistically from the preoperative values neither in the tumour 
nor the contralateral side. However, in the odour identification test, all posttreatment values were statistically significantly 
higher than pretreatment ones. In the olfactory threshold test, no statistically significant differences were found between pre- 
and posttreatment values. Electrogustometry values for the taste on the tumour side were statistically significantly impaired at 
6 weeks (p < 0.05) and at 3 months (p < 0.01) compared with the pretreatment results. They were also impaired at 6 months 
and at 12 months, although the differences were not statistically significant. The quality of life was impaired after treatment 
in this patient series. However, the correlation between quality of life and sense of taste was found only at one time point 
(3 months) and only with contralateral side measurements.
Conclusions We conclude that in oral and pharyngeal cancer patients the postoperative taste problems are related to the 
impairment on the taste sensation in the tongue but not with the sense of smell. Moreover, the impairment in the quality of 
life is not clearly related to the impaired sense of taste.
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Introduction
The aim of surgical treatment of oral and pharyngeal can-
cer consists of radical tumour resection with clear surgical 
margins and typically includes a neck dissection. Free tissue 
transfer reconstruction is an established and reliable tech-
nique for the reconstruction of the resultant tissue defect 
[1]. In addition, treatment is often supplemented by post-
operative radiotherapy or chemoradiotherapy. Breathing, 
speaking, chewing, and swallowing can be impaired by both 
cancer- and treatment-related factors [2]. The sense of taste 
can also be affected by the various interventions to the upper 
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aerodigestive area, as well as the tumour itself potentially 
destroying the oral mucosal lining, which encloses the taste 
buds [3]. The tumour may also disturb the food bolus prepa-
ration and prevent the aroma passing from the pharynx up to 
the nasal olfactory epithelium. Due to the close functional 
relationship between taste and smell sensations, it is obvious 
that flavor is a combination of both [4]. Self-reported disor-
ders of smell and taste are thus quite common, especially in 
head and neck cancer patients, but often underestimated by 
health-care workers [5, 6]. Furthermore, these problems may 
have a negative impact on the patient’s nutritional status, 
which in turn is known to impair tissue healing and may pre-
dispose to complications [7, 8]. However, despite the clinical 
relevance of the problem, there are only a few studies in the 
medical literature focusing on objectively measured altera-
tions in taste and smell among oral and pharyngeal cancer 
patients [5, 6].
The aim of this study was to evaluate both the sense of 
smell and taste amongst oral and pharyngeal cancer patients 
managed by surgical resection, free flap reconstruction 
and postoperative (chemo)radiotherapy. The effect of the 
disease itself and its treatment was studied by comparing 
preoperative and postoperative measurements during the 
1-year follow-up period. Additionally, any possible corre-
lation between the sensory changes and quality of life was 
evaluated.
Patients and methods
The study population consisted of 44 consecutive patients 
treated for carcinoma in the oral cavity, oropharynx or 
hypopharynx with curative intent by tumour resection and 
microvascular free tissue transfer reconstruction at the Hel-
sinki University Hospital (HUH). A multidisciplinary head 
and neck tumour board evaluated the treatment modality 
for each case.
The sociodemographic and medical characteristics of the 
44 patients are listed in Table 1. Mean age was 56.2 years 
(range 38–80). This study was part of a larger prospec-
tive study [2]. Smell and taste were measured prospec-
tively together with a number of other functional param-
eters. The results of the other functional studies have been 
published previously [2]. Thirty-nine (89%) out of the 44 
patients received radiotherapy, but the olfactory area was 
not included in the radiation field in any of the patients. The 
senses of smell and taste were evaluated preoperatively, and 
at 6 weeks, 3 months, 6 months and 12 months after treat-
ment. For the assessment of smell, both a detection test and 
a threshold test were used. Fourteen patients died during 
the 1-year follow-up. After 6 weeks there were 39 patients, 
after 3 months 38, after 6 months 35 and after 12 months 30 
patients still alive and eligible to be evaluated. The Research 
Ethics Board at HUH approved the study design and an insti-
tutional study permission was granted.
The odour detection and identification tests
The patient was asked to sniff seven different odours (coffee, 
cinnamon, spirit, vanillin, camphor, turpentine and gaso-
line). Detection without identification of the odour as well 
as specific odour identification were both assessed. Results 
were given as the sum of the positive answers. Each nostril 
(tumour side and contralateral side) was tested separately.
The olfactory threshold test
The detailed method has been published elsewhere [9, 10]. 
A commercially available smell test kit (Olfactory-Labs, 
Berkeley, California) was used. At each step of the test, the 
patient had to choose between the phenylethyl methyl ethyl 
carbinol sniff bottle and the control bottle containing the 
plain diluent, and was repeated three times. The weakest 
concentration at which the patient selected the correct bottle 
all three times was accepted as the olfactory threshold. The 
manufacturer expressed the concentrations using arbitrary 
Table 1  Medical and sociodemographic characteristics of 44 patients 
with oral or pharyngeal cancer
TRAM transverse rectus abdominis myocutaneous
a Heavy (over 5 standard units of alcohol/day)
Characteristics N (%)
Sex (male/female) 29 (66)/15 (34)
Smoking (yes/no) 31 (70)/13 (30)
Alcohol consumption (no or moderate/
heavya)
26 (59)/18 (41)
Tumour site
 Oral cavity 28 (64)
 Oropharynx 13 (29)
 Hypopharynx 3 (7)
 Tumour size (T2/T3/T4) 20 (45)/5 (11)/11 (25)
 Stage (II/III/IV) 10 (23)/8 (18)/18 (41)
 Tumour recurrence (typically large or 
multifocal)
8 (18)
Free flap type
 Radial forearm 34 (77)
 Latissimus dorsi and scapular 4 (9)
 Latissimus dorsi 2 (5)
 Fibula 1 (2)
 Jejunum 1 (2)
 Scapular 1 (2)
 TRAM 1 (2)
Neck dissection (unilateral/bilateral/none) 33 (75)/7 (16)/4 (9)
Radiotherapy timing (before/after surgery) 5 (11)/34 (77)
Concomitant chemotherapy 4 (9)
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logarithmic units (ALU). The concentrations in use were 
− 25, − 15, − 5, 5, 15, 25, 35, 45, and 55 ALU. A test result 
> 55 was awarded when the patient failed to smell the high-
est concentration. In the threshold test, the patient used both 
nostrils at the same time.
The gustatory test
The examination of the sense of taste was performed using 
electrogustometry (Rion TR-06 electrogustometer 6, Sen-
sonics, Inc., Haddon Heights, NJ, USA). Both sides of the 
tongue were tested separately. The tongue was stimulated 
by a short electrical impulse and the intensity was gradually 
increased (10, 20, 40, 100, 200 and 400 µA) until the patient 
had a positive sensation. The value > 400 µA was awarded 
when the highest impulse did not cause a sensation. The 
positive sensation for the patients resembles the one when 
a battery is pressed against tongue. The tumour side and 
contralateral side were tested separately. An approximate 
value of 100 µA or less can be considered as normal taste 
sensation.
Quality of life
The University of Washington Quality-of-Life Question-
naire (UW-QOL) was used for the evaluation. Nine ques-
tions (pain, disfigurement, activity, recreation/entertainment, 
employment, chewing, swallowing, speech, shoulder dis-
ability) were rated according to a scale from 0 (the greatest 
dysfunction) to 100 (best function). For a final composite 
score (0–100), the total score (maximum 900) was divided 
by nine. The questionnaire was completed before operation 
and four times postoperatively (6 weeks, 3 months, 6 months 
and 12 months after operation).
Statistical analysis
Data analysis and statistical tests were performed with the 
help of a professional statistician. Descriptive analyses 
(frequency, mean, standard deviation, etc.) were calcu-
lated using NCSS 8 (LLC, Kaysville, Utah, USA). Dif-
ferences between the groups were tested using Wilcoxon 
rank-sum test and the Spearman test was used to evaluate 
correlations. p values of < 0.05 were considered statisti-
cally significant.
Results
Odour detection and identification tests
In the preoperative detection test, the mean value ± stand-
ard deviation was 6.50 ± 0.65 on the tumour side and 
6.72 ± 0.51 on the contralateral side and in the preopera-
tive identification test 2.44 ± 1.50 and 2.38 ± 1.27, respec-
tively. In the odour detection and identification tests, there 
were no statistically significant differences between the 
tumour and the contralateral side neither in the pre- and 
posttreatment measurements. There were higher scores in 
the odour detection values in the 6 weeks and 3-month 
tests compared with preoperative values for the tumour 
side. Other detection scores did not differ statistically from 
the preoperative values neither in the tumour nor the con-
tralateral side. However, in the odour identification tests, 
all postoperative values were statistically significantly 
higher than preoperative ones. Differences between pre-
operative situation and each postoperative test (6 weeks, 
3 months, 6 months and 12 months) are shown in Tables 2 
and 3.
Table 2  Odour test (detection) 
values compared with the 
corresponding postoperative 
values
Detection test Tumour side Contralateral side
Preoperative vs. 6 weeks (N = 25) 6.48 ± 0.71 vs. 6.84 ± 0.47 (p < 0.01) 6.8 ± 0.41 vs. 6.76 ± 1.01
Preoperative vs. 3 months (N = 28) 6.50 ± 0.69 vs. 6.86 ± 0.45 (p < 0.05) 6.79 ± 0.42 vs. 6.75 ± 0.52
Preoperative vs. 6 months (N = 25) 6.56 ± 0.65 vs. 6.68 ± 0.63 6.80 ± 0.41 vs. 6.76 ± 0.52
Preoperative vs. 12 months (N = 18) 6.50 ± 0.71 vs. 6.78 ± 0.55 6.83 ± 0.38 vs. 6.78 ± 0.55
Table 3  Odour test (identification) values compared with the corresponding postoperative values
Detection test Tumour side Contralateral side
Preoperative vs. 6 weeks (N = 25) 2.60 ± 1.61 vs. 3.32 ± 1.89 (p < 0.05) 2.52 ± 1.36 vs. 3.36 ± 1.96 (p < 0.01)
Preoperative vs. 3 months (N = 28) 2.46 ± 1.57 vs. 3.39 ± 1.93 (p < 0.01) 2.36 ± 1.31 vs. 3.39 ± 2.08 (p < 0.01)
Preoperative vs. 6 months (N = 25) 2.52 ± 1.48 vs. 3.52 ± 2.02 (p < 0.01) 2.48 ± 1.26 vs. 3.64 ± 1.82 (p < 0.01)
Preoperative vs. 12 months (N = 18) 2.39 ± 1.65 vs. 3.72 ± 2.11 (p < 0.05) 2.44 ± 1.34 vs. 3.83 ± 1.92 (p < 0.01)
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Olfactory threshold test
Almost two-thirds (63.9%) of patients had a preoperative 
threshold test result of less than 35 ALU (normal) and 36.1% 
between 35 and 55 ALU (hyposmia). In the postoperative 
measurements, only one patient (3.6%) at 6 weeks, one 
(3.2%) at 3 months, and two patients (10%) at 12 months 
had a value of more than 55 ALU (anosmia). There were 
no statistically significant differences between any of the 
preoperative and postoperative values (Fig. 1).
Sense of taste (electrogustometry)
The preoperative electrogustometry result of the contralat-
eral side was 100 µA or less in 85.7% of tested patients com-
pared with 64.3% in the tumour side (Fig. 2) (p < 0.05). In 
the tumour side, electrogustometry values were statistically 
significantly impaired after surgery at 6 weeks (p < 0.05) 
and at 3 months (p < 0.01) compared with the preoperative 
situation. Also, the 6 and 12 months measurements were 
impaired, although the differences were not statistically sig-
nificant (Fig. 3). The changes in the contralateral values were 
not statistically significant (Fig. 4).
The correlations between electrogustometry values and 
body mass index, smoking years, alcohol consumption, the 
stage of disease, tumour size, tumour site, type of operation 
(mandibulotomy vs. non mandibulotomy, neck procedure) 
were calculated. Statistically significant correlations were 
found between preoperative taste on the tumour side and 
tumour size (p < 0.01) and between smoking years and taste 
on the contralateral side at 6 weeks (p < 0.05) and 6 months 
(p < 0.001) postoperatively. In other cases, either statistically 
significant correlation was not found or the number of cases 
in groups was too small for statistical testing.
Fig. 1  Preoperative and post-
operative (6 weeks, 3 months, 
6 months, 12 months) olfactory 
threshold test results divided 
into subgroups. The percentages 
of the subgroups are shown. 
Postoperative values do not 
differ statistically significantly 
when compared with the preop-
erative ones
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< 35 ALU 35 - 55 ALU > 55 ALU
Fig. 2  Preoperative electrogus-
tometry test results of the con-
tralateral side and the tumour 
side divided into subgroups. 
The percentages of the sub-
groups are shown. A statistically 
significant difference (p < 0.05) 
was found between contralateral 
and tumour side values
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Quality of life
The mean preoperative composite score was 83.5 and post-
operatively at 6 weeks, and at 3, 6, and 12 months 76.2, 75.6, 
76.6, and 79.8, respectively (p < 0.0001). A breakdown of 
the domain scores before and after operation and the signifi-
cance of any change are presented in Table 4. These results 
have been previously reported in detail [11]. For this study, 
the correlation between electrogustometry result and quality 
of life was tested. The mean composite score and individual 
domain scores 3 (activity), 4 (recreation/entertainment), 6 
(chewing) and 7 (swallowing) were tested separately. Only 
contralateral side taste at 3 months after treatment demon-
strated a statistically significant correlation with the qual-
ity of life. This correlation was seen with the composite 
score (Spearman’s coefficient (r) = − 0.63, p < 0.05), and 
domain scores 3 (activity) (r = 0.55, p < 0.05), 6 (chew-
ing) (r = − 0.58, p < 0.05) and 7 (swallowing) (r = − 0.63, 
p < 0.05). In all cases, the decreased sense of taste showed 
a correlation with a lower quality of life. The correlations 
between olfactory results and quality of life were not ana-
lyzed since the olfactory results improved after surgery, 
whereas the quality of life results were worse. 
Discussion
This is a prospective follow-up study of a series of 44 
patients with head and neck cancer affecting the upper aerod-
igestive tract who underwent multimodality therapy for their 
cancer. Olfactory and gustatory senses were tested to analyse 
the effect of their cancer treatment on these functions. We 
Fig. 3  Preoperative and post-
operative (6 weeks, 3 months, 
6 months, 12 months) elec-
trogustometry test results of 
the tumour side divided into 
subgroups. The percentages 
of the subgroups are shown. 
All postoperative results were 
statistically compared with the 
preoperative ones
p<0.05 p<0.01 NS NS
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Fig. 4  Preoperative and post-
operative (6 weeks, 3 months, 
6 months, 12 months) electro-
gustometry test results of the 
contralateral side divided into 
subgroups. The percentages 
of the subgroups are shown. 
Statistically significant differ-
ences between preoperative and 
postoperative results were not 
found
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found that there is postoperatively impairment in the sense 
of taste but an improvement in the sense of smell.
We found that the sense of taste of the tumour side of 
the tongue tested by electrogustometry was preoperatively 
weaker than that of the contralateral side. This could be 
a sign of tumour-related disturbance of the sense of taste 
since the decreased taste was also positively correlated with 
the tumour size. As expected, the taste of the affected side 
decreased after surgery when it was tested by electrogustom-
etry but the contralateral side remained unchanged. Three 
cranial nerves (CN) mediate the sense of taste. Facial nerve 
(CN VII) is responsible for the anterior two-thirds of the 
tongue and glossopharyngeal nerve (CN IX) for the posterior 
one-third. Vagal nerve (CN X) innervates the taste buds on 
the laryngeal surface of the epiglottis but its role in taste 
sensation is unclear. In addition, lingual nerve, a branch of 
the trigeminal nerve (CN V), supplies the sensory innerva-
tion to the tongue. It also carries the fibers from facial nerve 
via chorda tympani. Both the tumour and particularly its 
operative treatment can damage lingual and glossopharyn-
geal nerves. The study by Yamashita et al. suggested that 
radiotherapy results in damage to mainly the taste buds but 
not to the nerve fibers of the nerves involved in taste func-
tions. In addition, they showed that the negative impact 
of radiotherapy on the sense of taste was at least partially 
reversible [12]. Mirza et al. [13] reported that radiotherapy 
for head and neck cancer impaired the sense of sour taste. In 
addition, they found that the amount of taste pores decreased 
during the treatment. In the study by Sandow et al. [14], 13 
patients were treated by radiotherapy for primary tumours 
of the oropharynx. The study showed that the sense of taste 
was impaired during radiotherapy (the measurement was 
done at 1 month after the initiation of therapy), but it was 
normalized at 6 months after end of treatment. Mossman 
et al. [15] studied taste function in 13 patients treated by 
radiotherapy 1–7 years previously for tumours of the head 
and neck. They found subjective hypogeusia in 2 out of their 
13 (15%) patients and objective taste impairment in 9 out of 
13 (69%) patients. The taste impairment after radiotherapy 
can thus also be long lasting. In the present series, most 
patients received radiotherapy and therefore evaluation of 
its effect was impossible.
In the present series, there was no statistically signifi-
cant decrease in the sense of smell according to either the 
detection test or the threshold test when preoperative and 
postoperative values were compared. In fact, the study sub-
jects identified smells even better postoperatively than pre-
operatively. There are several potential explanations for this 
finding, e.g. stopping smoking, but further studies would 
be needed to clarify the mechanism of this phenomenon. 
Smoking has been shown to impair the sense of smell [16]. 
This effect is long lasting but reversible. The same study 
also showed that the improvement in smell function after the 
cessation of smoking is a slow phenomenon. Unfortunately, 
we did not record data on smoking cessation and its possi-
ble effects. We compared pre- and postoperative results and 
the study subjects served as their own controls. Therefore, 
although it is known that the sense of smell is age-related, 
we did not calculate age-related values for hyposmia and 
anosmia [17]. Both the odour detection and the identification 
tests and the olfactory threshold test were in clinical use at 
our department during the study period. Radiotherapy may 
negatively affect the sense of smell [18, 19]. However, while 
almost all (89%) patients in this series received radiotherapy, 
the olfactory area was not included in the radiation field. The 
low preoperative scores and the increase in the postopera-
tive smell detection and threshold could be explained by the 
effect of the tumour smell itself intervening with olfactory 
functions.
The University of Washington Quality-of-Life Ques-
tionnaire (UW-QOL) is composed of nine questions, 
which deal with pain, disfigurement, activity, recreation/
entertainment, employment, chewing, swallowing, speech, 
and shoulder disability. The correlation between the sense 
Table 4  UW-QOL domain 
scores in patients with oral 
cavity and oropharyngeal 
tumour
UW-QOL University of Washington Head and Neck Questionnaire, NS not significant
Significances of p values for the change from the preoperative score are presented in parentheses in three 
categories as follows: *< 0.05, **< 0.01, ***< 0.001
Domain Presentation 6 weeks 3 months 6 months 12 months
Pain 76.42 86.52(*) 81.25(NS) 85.00(NS) 89.14(**)
Disfigurement 96.17 78.18(***) 79.47(***) 81.1(***) 82.14(***)
Activity 88.33 79.47(**) 81.82(**) 83.61(NS) 92.14(NS)
Recreation/entertainment 93.25 80.24(**) 84.45(**) 85.56(**) 92.43(NS)
Employment 62.58 66.48(NS) 64.83(NS) 60.56(NS) 50.29(*)
Chewing 73.33 60.00(**) 57.89(**) 63.33(**) 66.00(*)
Swallowing 86.25 76.67(**) 74.52(**) 79.86(*) 83.93(NS)
Speech 95.31 80.25(***) 82.83(***) 81.25(***) 84.46(***)
Shoulder disability 97.08 78.59(***) 75.18(***) 73.26(***) 82.68(**)
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of taste and quality of life was found only at the 3-month 
time point and even then only with contralateral side meas-
urements. Of the nine single domains, activity, recreation/
entertainment, chewing and swallowing may be linked 
with taste. Thus, the sense of taste could not have a very 
strong impact on common scores. In addition, these four 
domains possibly linked with sense of taste were associ-
ated with several other factors, which may have a more 
significant predictive value. Therefore, it was understand-
able that the correlation between sense of taste and QOL 
scores was so weak.
Earlier studies have shown that smoking can impair the 
sense of taste and especially salty tasting [20, 21]. In the 
present study, 70% of the patients were smokers. Taste 
impairment was not correlated with the smoking status 
(nonsmoker, moderate smoker or heavy smoker) but instead 
it was correlated with smoking years. This correlation was 
seen on the contralateral side at 6 weeks and at 6 months. 
However, at 12 months the patient number was too small for 
statistical testing.
Electrogustometry has its own strengths and weaknesses. 
However, it is not expensive and not time consuming. In 
addition, its sensitivity and specificity have been reported 
to be too low for screening purposes [22]. In particular, the 
sensitivity seems low and for this reason, the percentage of 
patients suffering from taste problems may have been under-
estimated in the present series. However, electrogustometry 
is useful for follow-up studies, as in the present study [23]. 
Preoperative and postoperative values, the change between 
time points was quite reliably comparable when the patients 
serve as their own controls.
We conclude that the taste problems of oral and pharyn-
geal patients after free flap reconstruction and radiotherapy 
were purely taste-related without increased deficits in the 
sense of smell. Preoperatively, the tumour itself may have 
had some negative effect on the sense of taste but clearly 
stronger impairment was found after the treatment. Although 
these patients clearly have an impaired sense of taste on the 
tumour side and impaired quality of life, there was no sta-
tistically significant correlation between these two domains. 
Better understanding of the importance of senses of smell 
and taste on patient satisfaction, motivation to maintain suf-
ficient eating pre-, peri- and posttreatment and during recov-
ery, warrants further studies with larger series size.
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